<?xml version='1.0' encoding='UTF-8'?><metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns="http://dublincore.org/documents/dcmi-terms/"><dcterms:title>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</dcterms:title><dcterms:identifier>https://doi.org/10.7939/DVN/10902</dcterms:identifier><dcterms:creator>Huang, Vivian</dcterms:creator><dcterms:creator>Elahi, Shokrollah</dcterms:creator><dcterms:creator>Madsen, Karen</dcterms:creator><dcterms:creator>Fedorak, Richard</dcterms:creator><dcterms:creator>Dieleman, Levinus</dcterms:creator><dcterms:creator>Wine, Eytan</dcterms:creator><dcterms:creator>Lumb, Rowan</dcterms:creator><dcterms:publisher>UAL Dataverse</dcterms:publisher><dcterms:issued>2016-10-21</dcterms:issued><dcterms:modified>2017-05-26T21:13:06Z</dcterms:modified><dcterms:description>The objective of this study was to evaluate whether a FCP measurement in the 2nd or 3rd trimester of pregnancy in women with IBD can predict preterm delivery.</dcterms:description><dcterms:subject>Medicine, Health and Life Sciences</dcterms:subject><dcterms:subject>Crohn's disease</dcterms:subject><dcterms:subject>pregnancy</dcterms:subject><dcterms:subject>ulcerative colitis</dcterms:subject><dcterms:subject>cohort studies</dcterms:subject><dcterms:subject>infant</dcterms:subject><dcterms:subject>biomarkers</dcterms:subject><dcterms:subject>C-reactive protein</dcterms:subject><dcterms:subject>inflammatory bowel diseases</dcterms:subject><dcterms:subject>faecal calprotectin</dcterms:subject><dcterms:date>2015</dcterms:date><dcterms:dateSubmitted>2016-09-29</dcterms:dateSubmitted><dcterms:temporal>2014</dcterms:temporal><dcterms:temporal>2017</dcterms:temporal><dcterms:temporal>2014</dcterms:temporal><dcterms:temporal>2017</dcterms:temporal><dcterms:relation>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</dcterms:relation><dcterms:relation>Immunological Profiling</dcterms:relation><dcterms:type>Clinical data; Biosamples</dcterms:type><dcterms:spatial>Alberta</dcterms:spatial><dcterms:spatial>Edmonton</dcterms:spatial><dcterms:spatial>Canada</dcterms:spatial><dcterms:license>NONE</dcterms:license></metadata>